Mirja Heikkinen

Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study

Ritva Valavaara, Seppo Pyrhönen, Mirja Heikkinen et al. · European Journal of Cancer and Clinical Oncology · 1988 · 100 citations

Molecular Pharmacology, Advanced Breast Cancer, Breast Oncology +10

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading

Guillermo Blanco, K Holli, Mirja Heikkinen et al. · British Journal of Cancer · 1990 · 79 citations · Full text

Prognostic Factors, Breast Oncology, Medicine +10

Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the scandinavian glioblastoma study group

Reidulv Hatlevoll, Karl Fr. Lindegaard, Steinar Hagen et al. · Cancer · 1985 · 63 citations

Pharmacotherapy, High-grade Gliomas, Glioma +18

Breast cancer recurrence after mastectomy: diagnosis with mammography and US.

Tarja Rissanen, H Mäkäräinen, Seija I. Mattila et al. · Radiology · 1993 · 60 citations

Surgical Oncology, Breast Oncology, Diagnosis +19

Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.

Guillermo Blanco, M. Alavaikko, A Ojala et al. · PubMed · 1985 · 49 citations

Breast Oncology, Progesterone Receptor, Progesterone Receptors +14